why choose us

First received: April 09, 2023

Clinical Trial: CANF-Comb-II PET-MR in Atherosclerosis Multisite

Study Status: Completed

Recruit Status: RECRUITING

Condition: Carotid Atherosclerosis

Study Type: OBSERVATIONAL


Official Title: PET-MR Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis With Cu[64]-25%-CANF-Comb-II

Brief Summary: The goal of this observational study is to learn more about plaque biology in asymptomatic carotid artery stenosis (ACAS) patients through imaging.The main questions it aims to answer are:To determine the ability of 64Cu-CANF-Comb positron emission tomography (PET) to risk stratify ACAS patients for stroke event, to include transient ischemic attack or remote ipsilateral intervention.To further understand the role of Natriuretic Peptide Receptor C (NPRC) in the evolution of carotid atherosclerosis.Participants…

Read more